{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:12:58Z","timestamp":1775243578845,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004252","name":"Qatar University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004252","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21668-1","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:38:46Z","timestamp":1761752326000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ketamine and dodecyl maltoside synergy as a potential topical therapeutic approach for melanoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Sourour","family":"Idoudi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel","family":"Kheraldine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gazala","family":"Anamangadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumayyah","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fareed","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maysaloun","family":"Merhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Amine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Alansari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semir","family":"Vranic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamda","family":"Al-Thawadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ousama","family":"Rachid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaaldin M.","family":"Alkilany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"key":"21668_CR1","doi-asserted-by":"publisher","unstructured":"Hsieh, M. Y., Hsu, S. K., Liu, T. Y., Wu, C. Y. & Chiu, C. C. Melanoma biology and treatment: a review of novel regulated cell death-based approaches. Cancer Cell Int 2024 241 [Internet]. 2024 Feb 9 [cited 2024 Oct 21];24(1):1\u201321. Available from: https:\/\/cancerci.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12935-024-03220-9","DOI":"10.1186\/s12935-024-03220-9"},{"key":"21668_CR2","doi-asserted-by":"crossref","unstructured":"Ali, Z., Yousaf, N. & Larkin, J. Melanoma epidemiology, biology and prognosis. EJC Suppl [Internet]. Sep [cited 2024 Oct 22];11(2):81. (2013). Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4041476\/","DOI":"10.1016\/j.ejcsup.2013.07.012"},{"key":"21668_CR3","doi-asserted-by":"crossref","unstructured":"Chang, A. E., Karnell, L. H. & Menck, H. R. The National cancer data base report on cutaneous and noncutaneous melanoma A summary of 84,836 cases from the past decade. Cancer 83 (8), 1664\u20131678 (1998).","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G"},{"key":"21668_CR4","doi-asserted-by":"crossref","unstructured":"Slominski, R. M. et al. Melanoma, Melanin, and Melanogenesis: The Yin and Yang Relationship. Front Oncol [Internet]. 2022 Mar 14 [cited 2024 Nov 8];12:842496. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8963986\/","DOI":"10.3389\/fonc.2022.842496"},{"key":"21668_CR5","doi-asserted-by":"publisher","unstructured":"Saud, A., Sagineedu, S. R., Ng, H. S., Stanslas, J. & Lim, J. C. W. Melanoma metastasis: What role does melanin play? (Review). Oncol Rep [Internet]. 2022 Dec 1 [cited 2024 Nov 8];48(6):1\u201310. Available from: http:\/\/www.spandidos-publications.com\/https:\/\/doi.org\/10.3892\/or.2022.8432\/abstract","DOI":"10.3892\/or.2022.8432\/abstract"},{"key":"21668_CR6","doi-asserted-by":"publisher","unstructured":"Leong, S. P. & Witte, M. H. Cancer metastasis through the lymphatic versus blood vessels. Clin Exp Metastasis [Internet]. 2024 Aug 1 [cited 2024 Nov 8];41(4):387\u2013402. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s10585-024-10288-0","DOI":"10.1007\/s10585-024-10288-0"},{"key":"21668_CR7","doi-asserted-by":"crossref","unstructured":"Gherzi, L., Ferrari, M. & Pardolesi, A. Lung metastases from sarcoma: multidisciplinary approach\u2014a narrative review. AME Surg J [Internet]. Dec 1 [cited 2024 Nov 8];2(0):38\u201338. (2022). Available from: https:\/\/asj.amegroups.org\/article\/view\/58315","DOI":"10.21037\/asj-21-68"},{"key":"21668_CR8","doi-asserted-by":"publisher","unstructured":"Kimchy, A. V. et al. The Predictive Value of Liver Tests for the Presence of Liver Metastases. Hepatic Oncol [Internet]. 2023 Aug 1 [cited 2024 Nov 8];10(3). Available from: https:\/\/www.tandfonline.com\/doi\/abs\/https:\/\/doi.org\/10.2217\/hep-2023-0003","DOI":"10.2217\/hep-2023-0003"},{"key":"21668_CR9","doi-asserted-by":"crossref","unstructured":"Andryszkiewicz, W. et al. Cancer Metastases to the Liver: Mechanisms of Tumor Cell Colonization. Pharm. Vol 17, Page 1251 [Internet]. 2024 Sep 23 [cited 2024 Nov 8];17(9):1251. (2024). Available from: https:\/\/www.mdpi.com\/1424-8247\/17\/9\/1251\/htm","DOI":"10.3390\/ph17091251"},{"key":"21668_CR10","doi-asserted-by":"crossref","unstructured":"Diaz, M. J. et al. Melanoma Brain Metastases: A Systematic Review of Opportunities for Earlier Detection, Diagnosis, and Treatment. Life [Internet]. 2023 Mar 1 [cited 2024 Nov 8];13(3):828. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10053844\/","DOI":"10.3390\/life13030828"},{"key":"21668_CR11","doi-asserted-by":"crossref","unstructured":"Avino, A. et al. Diagnostic and Therapeutic Particularities of Symptomatic Melanoma Brain Metastases from Case Report to Literature Review. Diagnostics 2024, Vol 14, Page 688 [Internet]. 2024 Mar 25 [cited 2024 Nov 8];14(7):688. (2075). Available from: https:\/\/www.mdpi.com\/-4418\/14\/7\/688\/htm.","DOI":"10.3390\/diagnostics14070688"},{"key":"21668_CR12","doi-asserted-by":"crossref","unstructured":"Sukniam, K., Manaise, H. K., Popp, K., Popp, R. & Gabriel, E. Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics. Cells 2024, Vol 13, Page 465 [Internet]. 2024 Mar 7 [cited 2024 Nov 8];13(6):465. (2073). Available from: https:\/\/www.mdpi.com\/-4409\/13\/6\/465\/htm.","DOI":"10.3390\/cells13060465"},{"key":"21668_CR13","doi-asserted-by":"crossref","unstructured":"Natarelli, N. et al. A Review of Current and Pipeline Drugs for Treatment of Melanoma. Pharm 2024, Vol 17, Page 214 [Internet]. 2024 Feb 7 [cited 2024 Nov 8];17(2):214. Available from: https:\/\/www.mdpi.com\/1424-8247\/17\/2\/214\/htm","DOI":"10.3390\/ph17020214"},{"key":"21668_CR14","doi-asserted-by":"crossref","unstructured":"Druskovich, C., Kelley, J., Aubrey, J., Palladino, L. & Wright, G. P. A Review of Melanoma Subtypes: Genetic and Treatment Considerations. J Surg Oncol [Internet]. 2024 Mar 1 [cited 2025 Aug 9];131(3):356. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC12044287\/","DOI":"10.1002\/jso.27953"},{"key":"21668_CR15","doi-asserted-by":"crossref","unstructured":"Yang, T. T., Yu, S., Ke, C. L. K. & Cheng, S. T. The Genomic Landscape of Melanoma and Its Therapeutic Implications. Genes. Vol 14, Page 1021 [Internet]. 2023 Apr 29 [cited 2025 Aug 9];14(5):1021. (2023). Available from: https:\/\/www.mdpi.com\/2073-4425\/14\/5\/1021\/htm","DOI":"10.3390\/genes14051021"},{"key":"21668_CR16","unstructured":"Bhatia, S., Tykodi, S. S. & Thompson, J. A. Treatment of Metastatic Melanoma: An Overview. Oncology (Williston Park) [Internet]. 2009 May [cited 2025 Aug 9];23(6):488. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2737459\/"},{"key":"21668_CR17","doi-asserted-by":"crossref","unstructured":"Kim, C. et al. Long-Term Survival in Patients with Metastatic Melanoma Treated with DTIC or Temozolomide. Oncologist [Internet]. Jul 1 [cited 2025 Aug 9];15(7):765. (2010). Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3228011\/","DOI":"10.1634\/theoncologist.2009-0237"},{"key":"21668_CR18","doi-asserted-by":"crossref","unstructured":"Fateeva, A., Eddy, K. & Chen, S. Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance. Cancers. Vol 16, Page 1571 [Internet]. 2024 Apr 19 [cited 2024 Nov 8];16(8):1571. (2024). Available from: https:\/\/www.mdpi.com\/2072-6694\/16\/8\/1571\/htm","DOI":"10.3390\/cancers16081571"},{"key":"21668_CR19","doi-asserted-by":"crossref","unstructured":"Al Hmada, Y. et al. Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells. Cancers 2024, Vol 16, Page 470 [Internet]. 2024 Jan 22 [cited 2024 Nov 9];16(2):470. (2072). Available from: https:\/\/www.mdpi.com\/-6694\/16\/2\/470\/htm.","DOI":"10.3390\/cancers16020470"},{"key":"21668_CR20","doi-asserted-by":"publisher","unstructured":"Hodi, F. S. et al. Long-term survival in advanced melanoma for patients treated with nivolumab plus ipilimumab in CheckMate 067. J Clin Oncol [Internet]. 2022 Jun 1 [cited 2024 Oct 21];40(16_suppl):9522\u20139522. Available from: https:\/\/doi.org\/10.1200\/JCO.2022.40.16_suppl.9522","DOI":"10.1200\/JCO.2022.40.16_suppl.9522"},{"key":"21668_CR21","doi-asserted-by":"crossref","unstructured":"Nikolaou, V., Tsimpidakis, A. & Stratigos, A. Cutaneous Adverse Reactions of Immunotherapy in Patients with Advanced Melanoma. Cancers (Basel) [Internet]. 2023 Apr 1 [cited 2024 Nov 9];15(7):2084. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10093334\/","DOI":"10.3390\/cancers15072084"},{"key":"21668_CR22","unstructured":"De Rosa, M. C., Purohit, R. & Garc\u00eda-Sosa, A. T. Drug repurposing: a nexus of innovation, science, and potential. Sci Reports 2023 131 [Internet]. 2023 Oct 19 [cited 2024 Nov 9];13(1):1\u20133. Available from: https:\/\/www.nature.com\/articles\/s41598-023-44264-7"},{"key":"21668_CR23","unstructured":"Xia, Y., Sun, M., Huang, H. & Jin, W. L. Drug repurposing for cancer therapy. Signal Transduct Target Ther 2024 91 [Internet]. 2024 Apr 19 [cited 2024 Nov 9];9(1):1\u201333. Available from: https:\/\/www.nature.com\/articles\/s41392-024-01808-1"},{"issue":"7","key":"21668_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines10071589","volume":"10","author":"KC Wu","year":"2022","unstructured":"Wu, K. C., Liao, K. S., Yeh, L. R. & Wang, Y. K. Drug repurposing: the mechanisms and signaling pathways of Anti-Cancer effects of anesthetics. Biomedicines 10 (7), 1\u201326 (2022).","journal-title":"Biomedicines"},{"key":"21668_CR25","doi-asserted-by":"crossref","unstructured":"Weth, F. R. et al. Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy. Br J Cancer 2023 1305 [Internet]. 2023 Nov 27 [cited 2024 Nov 9];130(5):703\u201315. Available from: https:\/\/www.nature.com\/articles\/s41416-023-02502-9","DOI":"10.1038\/s41416-023-02502-9"},{"key":"21668_CR26","doi-asserted-by":"crossref","unstructured":"Kulkarni, V. S., Alagarsamy, V., Solomon, V. R., Jose, P. A. & Murugesan, S. Drug Repurposing: An Effective Tool in Modern Drug Discovery. Russ J Bioorganic Chem [Internet]. 2023 Apr 1 [cited 2024 Nov 9];49(2):157. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9945820\/","DOI":"10.1134\/S1068162023020139"},{"key":"21668_CR27","doi-asserted-by":"crossref","unstructured":"Krishnamurthy, N., Grimshaw, A. A., Axson, S. A., Choe, S. H. & Miller, J. E. Drug repurposing: a systematic review on root causes, barriers and facilitators. BMC Health Serv Res [Internet]. 2022 Dec 1 [cited 2024 Nov 9];22(1):970. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9336118\/","DOI":"10.1186\/s12913-022-08272-z"},{"key":"21668_CR28","unstructured":"Zhang, Z. et al. Overcoming cancer therapeutic bottleneck by drug repurposing. Signal Transduct Target Ther 2020 51 [Internet]. 2020 Jul 2 [cited 2025 Aug 9];5(1):1\u201325. Available from: https:\/\/www.nature.com\/articles\/s41392-020-00213-8"},{"key":"21668_CR29","doi-asserted-by":"crossref","unstructured":"Rastegar-Pouyani, N. et al. Targeting cancer-associated fibroblasts with pirfenidone: A novel approach for cancer therapy. Tissue Cell [Internet]. 2024 Dec 1 [cited 2025 Aug 9];91. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/39581071\/","DOI":"10.1016\/j.tice.2024.102624"},{"key":"21668_CR30","doi-asserted-by":"publisher","unstructured":"Rastegar-Pouyani, N., Farzin, M. A., Zafari, J., Haji Abdolvahab, M. & Hassani, S. Repurposing the anti-parasitic agent pentamidine for cancer therapy; a novel approach with promising anti-tumor properties. J Transl Med 2025 231 [Internet]. 2025 Mar 3 [cited 2025 Aug 9];23(1):1\u201320. Available from: https:\/\/translational-medicine.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12967-025-06293-w","DOI":"10.1186\/s12967-025-06293-w"},{"key":"21668_CR31","doi-asserted-by":"publisher","first-page":"100017","DOI":"10.1016\/j.ejcskn.2024.100017","volume":"2","author":"CY Wang","year":"2024","unstructured":"Wang, C. Y. et al. Statin use in resected, high-risk cutaneous melanoma: A multi-centre retrospective cohort study. EJC Ski Cancer. 2, 100017 (2024).","journal-title":"EJC Ski Cancer"},{"key":"21668_CR32","doi-asserted-by":"crossref","unstructured":"Irie, N. et al. Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin\u2013Dipyridamole Combination Treatment in Melanoma Cell Lines. Biomedicines [Internet]. 2024 Mar 1 [cited 2024 Nov 10];12(3):698. Available from: https:\/\/www.mdpi.com\/2227-9059\/12\/3\/698\/htm","DOI":"10.3390\/biomedicines12030698"},{"key":"21668_CR33","doi-asserted-by":"publisher","unstructured":"Jiang, W., Hu, J. W., He, X. R., Jin, W. L. & He, X. Y. Statins: a repurposed drug to fight cancer. J Exp Clin Cancer Res 2021 401 [Internet]. 2021 Jul 24 [cited 2024 Nov 10];40(1):1\u201333. Available from: https:\/\/jeccr.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s13046-021-02041-2","DOI":"10.1186\/s13046-021-02041-2"},{"key":"21668_CR34","doi-asserted-by":"publisher","unstructured":"McKechnie, T. et al. The impact of statins on melanoma survival: a systematic review and meta-analysis. Melanoma Res [Internet]. 2024 Dec 12 [cited 2024 Nov 10];34(6):475\u201386. Available from: https:\/\/journals.lww.com\/https:\/\/doi.org\/10.1097\/CMR.0000000000001001","DOI":"10.1097\/CMR.0000000000001001"},{"key":"21668_CR35","doi-asserted-by":"crossref","unstructured":"Liang, G. et al. Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K\/mTOR signaling pathways. Oncotarget [Internet]. [cited 2024 Nov 10];8(17):28510. (2017). Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5438669\/","DOI":"10.18632\/oncotarget.15324"},{"key":"21668_CR36","doi-asserted-by":"publisher","first-page":"113616","DOI":"10.1016\/j.biopha.2022.113616","volume":"154","author":"CL Li","year":"2022","unstructured":"Li, C. L. et al. Repurposed Itraconazole for use in the treatment of malignancies as a promising therapeutic strategy. Biomed. Pharmacother. 154, 113616 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"21668_CR37","doi-asserted-by":"publisher","unstructured":"Inoue, K., Tsubamoto, H., Isono-Nakata, R., Sakata, K. & Nakagomi, N. Itraconazole treatment of primary malignant melanoma of the vagina evaluated using positron emission tomography and tissue cDNA microarray: A case report. BMC Cancer [Internet]. 2018 Jun 4 [cited 2024 Nov 10];18(1):1\u20136. Available from: https:\/\/bmccancer.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12885-018-4520-5","DOI":"10.1186\/s12885-018-4520-5"},{"issue":"1","key":"21668_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2018","unstructured":"Pushpakom, S. et al. Drug repurposing: Progress, challenges and recommendations. Nat. Rev. Drug Discov. 18 (1), 41\u201358 (2018).","journal-title":"Nat. Rev. Drug Discov"},{"key":"21668_CR39","doi-asserted-by":"crossref","unstructured":"Hua, Y. et al. Drug repositioning: Progress and challenges in drug discovery for various diseases. Eur J Med Chem [Internet]. 2022 Apr 15 [cited 2024 Nov 10];234:114239. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC8883737\/","DOI":"10.1016\/j.ejmech.2022.114239"},{"key":"21668_CR40","doi-asserted-by":"crossref","unstructured":"Nikkheslat, N. Targeting inflammation in depression: Ketamine as an anti-inflammatory antidepressant in psychiatric emergency. Brain, Behav Immun - Heal. ;18:100383. (2021).","DOI":"10.1016\/j.bbih.2021.100383"},{"key":"21668_CR41","doi-asserted-by":"crossref","unstructured":"J\u00f3\u017awiak-BeRbenista, M., Soko\u0142owska, P., Wiktorowska-Owczarek, A., Kowalczyk, E. & Sienkiewicz, M. Ketamine \u2013 A New Antidepressant Drug with Anti-Inflammatory Properties. J Pharmacol Exp Ther [Internet]. 2024 Jan 1 [cited 2025 Jan 21];388(1):134\u201344. Available from: http:\/\/jpet.aspetjournals.org\/article\/S0022356524171443\/fulltext","DOI":"10.1124\/jpet.123.001823"},{"key":"21668_CR42","doi-asserted-by":"publisher","unstructured":"Peltoniemi, M. A., Hagelberg, N. M., Olkkola, K. T., Saari, T. I. & Ketamine A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy. Clin Pharmacokinet 2016 559 [Internet]. 2016 Mar 30 [cited 2024 Mar 5];55(9):1059\u201377. Available from: https:\/\/link.springer.com\/article\/https:\/\/doi.org\/10.1007\/s40262-016-0383-6","DOI":"10.1007\/s40262-016-0383-6"},{"key":"21668_CR43","doi-asserted-by":"publisher","unstructured":"Mion, G. & Villevieille, T. Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings). CNS Neurosci Ther [Internet]. Jun 1 [cited 2024 Jun 30];19(6):370\u201380. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/full\/ (2013). https:\/\/doi.org\/10.1111\/cns.12099","DOI":"10.1111\/cns.12099"},{"key":"21668_CR44","doi-asserted-by":"crossref","unstructured":"Saito, J. et al. Anti-cancer effect of ketamine in comparison with MK801 on neuroglioma and lung cancer cells. Eur. J. Pharmacol. 945, 175580 (2023).","DOI":"10.1016\/j.ejphar.2023.175580"},{"issue":"3","key":"21668_CR45","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cam4.1288","volume":"7","author":"X Zhou","year":"2018","unstructured":"Zhou, X. et al. Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD69. Cancer Med. 7 (3), 788\u2013795 (2018).","journal-title":"Cancer Med."},{"key":"21668_CR46","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.2147\/DDDT.S332847","volume":"15","author":"GN He","year":"2021","unstructured":"He, G. N. et al. Ketamine induces ferroptosis of liver cancer cells by targeting LncRNA PVT1\/miR-214-3p\/GPX4. Drug Des. Devel Ther. 15, 3965\u20133978 (2021).","journal-title":"Drug Des. Devel Ther."},{"issue":"5","key":"21668_CR47","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.5114\/aoms.2019.85146","volume":"16","author":"S Zhao","year":"2019","unstructured":"Zhao, S., Shao, L., Wang, Y., Meng, Q. & Yu, J. Ketamine exhibits anti-gastric cancer activity via induction of apoptosis and Attenuation of PI3K\/Akt\/mTOR. Arch. Med. Sci. 16 (5), 1140\u20131149 (2019).","journal-title":"Arch. Med. Sci."},{"key":"21668_CR48","doi-asserted-by":"publisher","unstructured":"Li, H. et al. Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5\/GPX4 axis. Biochem Biophys Res Commun [Internet]. ;585:111\u20136. (2021). Available from: https:\/\/doi.org\/10.1016\/j.bbrc.2021.11.029","DOI":"10.1016\/j.bbrc.2021.11.029"},{"key":"21668_CR49","doi-asserted-by":"publisher","unstructured":"Malsy, M. et al. Effects of ketamine, s-ketamine, and MK 801 on proliferation, apoptosis, and necrosis in pancreatic cancer cells. BMC Anesthesiol [Internet]. ;15(1):1\u20137. (2015). Available from: https:\/\/doi.org\/10.1186\/s12871-015-0076-y","DOI":"10.1186\/s12871-015-0076-y"},{"issue":"4","key":"21668_CR50","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.3892\/ol.2017.6806","volume":"14","author":"H Niwa","year":"2017","unstructured":"Niwa, H., Furukawa, K. I., Seya, K. & Hirota, K. Ketamine suppresses the proliferation of rat C6 glioma cells. Oncol. Lett. 14 (4), 4911\u20134917 (2017).","journal-title":"Oncol. Lett."},{"key":"21668_CR51","doi-asserted-by":"crossref","unstructured":"Ezike, T. C. et al. Advances in drug delivery systems, challenges and future directions. Heliyon [Internet]. 2023 Jun 1 [cited 2025 Aug 8];9(6):e17488. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10320272\/","DOI":"10.1016\/j.heliyon.2023.e17488"},{"key":"21668_CR52","doi-asserted-by":"crossref","unstructured":"Madden, S., Carrazana, E. & Rabinowicz, A. L. Optimizing Absorption for Intranasal Delivery of Drugs Targeting the Central Nervous System Using Alkylsaccharide Permeation Enhancers. Pharm 2023, Vol 15, Page 2119 [Internet]. 2023 Aug 10 [cited 2024 Jan 5];15(8):2119. (1999). Available from: https:\/\/www.mdpi.com\/-4923\/15\/8\/2119\/htm.","DOI":"10.3390\/pharmaceutics15082119"},{"key":"21668_CR53","doi-asserted-by":"publisher","unstructured":"Gholizadeh, A., Amjad-Iranagh, S. & Halladj, R. Assessing the Interaction between Dodecylphosphocholine and Dodecylmaltoside Mixed Micelles as Drug Carriers with Lipid Membrane: A Coarse-Grained Molecular Dynamics Simulation. ACS Omega [Internet]. [cited 2024 Nov 10]; Available from: https:\/\/pubs.acs.org\/doi\/full\/ (2024). https:\/\/doi.org\/10.1021\/acsomega.4c02551","DOI":"10.1021\/acsomega.4c02551"},{"issue":"4","key":"21668_CR54","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ejps.2012.08.010","volume":"47","author":"SB Petersen","year":"2012","unstructured":"Petersen, S. B. et al. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers. Eur. J. Pharm. Sci. 47 (4), 701\u2013712 (2012).","journal-title":"Eur. J. Pharm. Sci."},{"key":"21668_CR55","doi-asserted-by":"publisher","first-page":"646554","DOI":"10.3389\/fbioe.2021.646554","volume":"9","author":"YQ Yu","year":"2021","unstructured":"Yu, Y. Q., Yang, X., Wu, X. F., Fan, Y. & Bin Enhancing permeation of drug molecules across the skin via delivery in nanocarriers: novel strategies for effective transdermal applications. Front. Bioeng. Biotechnol. 9, 646554 (2021).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"21668_CR56","doi-asserted-by":"publisher","first-page":"123957","DOI":"10.1016\/j.ijpharm.2024.123957","volume":"654","author":"NW Larsen","year":"2024","unstructured":"Larsen, N. W. et al. Interactions of oral permeation enhancers with lipid membranes in simulated intestinal environments. Int. J. Pharm. 654, 123957 (2024).","journal-title":"Int. J. Pharm."},{"key":"21668_CR57","doi-asserted-by":"crossref","unstructured":"Aguirre-Ram\u00edrez, M., Silva-Jim\u00e9nez, H., Banat, I. M. & D\u00edaz De Rienzo, M. A. Surfactants: physicochemical interactions with biological macromolecules. Biotechnol Lett [Internet]. 2021 Mar 1 [cited 2024 Nov 10];43(3):523. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7872986\/","DOI":"10.1007\/s10529-020-03054-1"},{"issue":"2","key":"21668_CR58","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/jps.20234","volume":"94","author":"PP Tirumalasetty","year":"2005","unstructured":"Tirumalasetty, P. P. & Eley, J. G. Evaluation of dodecylmaltoside as a permeability enhancer for insulin using human carcinoma cells. J. Pharm. Sci. 94 (2), 246\u2013255 (2005).","journal-title":"J. Pharm. Sci."},{"key":"21668_CR59","doi-asserted-by":"crossref","unstructured":"Michael Danielsen, E. & Hansen, G. H. Probing the Action of Permeation Enhancers Sodium Cholate and N-dodecyl-\u03b2-D-maltoside in a Porcine Jejunal Mucosal Explant System. Pharm. Vol 10, Page 172 [Internet]. 2018 Oct 2 [cited 2024 Nov 10];10(4):172. (2018). Available from: https:\/\/www.mdpi.com\/1999-4923\/10\/4\/172\/htm","DOI":"10.3390\/pharmaceutics10040172"},{"key":"21668_CR60","doi-asserted-by":"publisher","unstructured":"Gradauer, K. et al. Dodecylmaltoside Modulates Bicellular Tight Junction Contacts to Promote Enhanced Permeability. Mol Pharm [Internet]. 2017 Dec 4 [cited 2024 Nov 10];14(12):4734\u201340. Available from: https:\/\/pubs.acs.org\/doi\/abs\/https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00297","DOI":"10.1021\/acs.molpharmaceut.7b00297"},{"key":"21668_CR61","doi-asserted-by":"crossref","unstructured":"Zhang, T., Li, M., Han, X., Nie, G. & Zheng, A. Effect of different absorption enhancers on the nasal absorption of Nalmefene hydrochloride. AAPS PharmSciTech. 23 (5), 143 (2022).","DOI":"10.1208\/s12249-022-02252-6"},{"key":"21668_CR62","doi-asserted-by":"publisher","unstructured":"Xia, Y. et al. Performance and toxicity of different absorption enhancers used in the preparation of Poloxamer thermosensitive in situ gels for ketamine nasal administration. Drug Dev Ind Pharm [Internet]. May 3 [cited 2024 Jan 2];46(5):697\u2013705. Available from: https:\/\/www.tandfonline.com\/doi\/abs\/ (2020). https:\/\/doi.org\/10.1080\/03639045.2020.1750625","DOI":"10.1080\/03639045.2020.1750625"},{"key":"21668_CR63","unstructured":"MDA-MB-435S - HTB. -129 | ATCC [Internet]. [cited 2025 Aug 27]. Available from: https:\/\/www.atcc.org\/products\/htb-129"},{"key":"21668_CR64","doi-asserted-by":"crossref","unstructured":"Geisse, J. K. et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study. J Am Acad Dermatol [Internet]. Sep 1 [cited 2025 Jun 3];47(3):390\u20138. (2002). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12196749\/","DOI":"10.1067\/mjd.2002.126215"},{"key":"21668_CR65","doi-asserted-by":"crossref","unstructured":"Jury, C. S., Ramraka-Jones, V. S., Gudi, V. & Herd, R. M. A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment. Br J Dermatol [Internet]. Oct [cited 2025 Jun 3];153(4):808\u201310. (2005). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/16181465\/","DOI":"10.1111\/j.1365-2133.2005.06858.x"},{"key":"21668_CR66","doi-asserted-by":"crossref","unstructured":"Kopsky, D. J. & Keppel Hesselink, J. M. Multimodal Stepped Care Approach Involving Topical Analgesics for Severe Intractable Neuropathic Pain in CRPS Type 1: A Case Report. Case Rep Med [Internet]. [cited 2025 Jun 3];2011. (2011). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22028723\/","DOI":"10.1155\/2011\/319750"},{"key":"21668_CR67","doi-asserted-by":"publisher","unstructured":"Rabinowicz, A. L., Carrazana, E. & Maggio, E. T. Improvement of Intranasal Drug Delivery with Intravail\u00ae Alkylsaccharide Excipient as a Mucosal Absorption Enhancer Aiding in the Treatment of Conditions of the Central Nervous System. Drugs R D [Internet]. Dec 1 [cited 2025 Jun 2];21(4):361\u20139. Available from: https:\/\/link.springer.com\/ (2021). https:\/\/doi.org\/10.1007\/s40268-021-00360-5","DOI":"10.1007\/s40268-021-00360-5"},{"key":"21668_CR68","doi-asserted-by":"crossref","unstructured":"Bai, J., Li, Y. & Zhang, G. Cell cycle regulation and anticancer drug discovery. Cancer Biol Med [Internet]. 2017 [cited 2025 Jan 6];14(4):348. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5785171\/","DOI":"10.20892\/j.issn.2095-3941.2017.0033"},{"key":"21668_CR69","unstructured":"Ma, C. & Gurkan-Cavusoglu, E. A comprehensive review of computational cell cycle models in guiding cancer treatment strategies. npj Syst Biol Appl 2024 101 [Internet]. 2024 Jul 5 [cited 2025 Jan 6];10(1):1\u201328. Available from: https:\/\/www.nature.com\/articles\/s41540-024-00397-7"},{"key":"21668_CR70","doi-asserted-by":"publisher","unstructured":"Wong, R. S. Y. Apoptosis in cancer: From pathogenesis to treatment. J Exp Clin Cancer Res [Internet]. Sep 26 [cited 2025 Jan 15];30(1):1\u201314. Available from: https:\/\/jeccr.biomedcentral.com\/articles\/ (2011). https:\/\/doi.org\/10.1186\/1756-9966-30-87","DOI":"10.1186\/1756-9966-30-87"},{"key":"21668_CR71","doi-asserted-by":"publisher","unstructured":"Lin, P. et al. Strategic disruption of cancer\u2019s powerhouse: precise nanomedicine targeting of mitochondrial metabolism. J Nanobiotechnology 2024 221 [Internet]. 2024 Jun 8 [cited 2025 Jan 15];22(1):1\u201326. Available from: https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12951-024-02585-3","DOI":"10.1186\/s12951-024-02585-3"},{"key":"21668_CR72","doi-asserted-by":"crossref","unstructured":"Li, X. et al. Administration of ketamine causes autophagy and apoptosis in the rat fetal hippocampus and in PC12 cells. Front. Cell. Neurosci. [Internet] 12, 324116 (2018). Available from: www.frontiersin.org","DOI":"10.3389\/fncel.2018.00021"},{"key":"21668_CR73","doi-asserted-by":"publisher","first-page":"110653","DOI":"10.1016\/j.fct.2019.110653","volume":"132","author":"Z Liang","year":"2019","unstructured":"Liang, Z., Yin, P. & Zhao, L. Effects of combined toxicity of methamphetamine and ketamine on apoptosis, oxidative stress and genotoxicity in HepG2 cells. Food Chem. Toxicol. 132, 110653 (2019).","journal-title":"Food Chem. Toxicol."},{"issue":"10","key":"21668_CR74","doi-asserted-by":"publisher","first-page":"119317","DOI":"10.1016\/j.bbamcr.2022.119317","volume":"1869","author":"P Wolf","year":"2022","unstructured":"Wolf, P., Schoeniger, A. & Edlich, F. Pro-apoptotic complexes of BAX and BAK on the outer mitochondrial membrane. Biochim. Biophys. Acta - Mol. Cell. Res. 1869 (10), 119317 (2022).","journal-title":"Biochim. Biophys. Acta - Mol. Cell. Res."},{"key":"21668_CR75","doi-asserted-by":"crossref","unstructured":"Korsmeyer, S. J. et al. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 2000 712 [Internet]. 2000 Dec 13 [cited 2025 Jan 12];7(12):1166\u201373. Available from: https:\/\/www.nature.com\/articles\/4400783","DOI":"10.1038\/sj.cdd.4400783"},{"key":"21668_CR76","doi-asserted-by":"crossref","unstructured":"Elmore, S. & Apoptosis A Review of Programmed Cell Death. Toxicol Pathol [Internet]. 2007 [cited 2025 Jan 12];35(4):495. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC2117903\/","DOI":"10.1080\/01926230701320337"},{"key":"21668_CR77","doi-asserted-by":"crossref","unstructured":"Parrish, A. B., Freel, C. D. & Kornbluth, S. Cellular Mechanisms Controlling Caspase Activation and Function. Cold Spring Harb Perspect Biol [Internet]. 2013 Jun [cited 2025 Jan 12];5(6):a008672. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC3660825\/","DOI":"10.1101\/cshperspect.a008672"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21668-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21668-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21668-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:39:36Z","timestamp":1761752376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21668-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21668"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21668-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Authors declared that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"37887"}}